Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer-Reference-Cited by-同舟云学术

Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer

Published:2021-07 Issue:1 Volume:206 Page:80-87
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

McKay Rana R.¹,Xie Wanling²,Ye Huihui³,Fennessy Fiona M.²,Zhang Zhenwei²,Lis Rosina²,Calagua Carla³⁴,Rathkopf Dana⁵,Laudone Vincent P.⁵,Bubley Glenn J.⁴,Einstein David J.⁴,Chang Peter K.⁴,Wagner Andrew A.⁴,Parsons J. Kellogg¹,Preston Mark A.²,Kilbridge Kerry²,Chang Steven L.²,Choudhury Atish D.²,Pomerantz Mark M.²,Trinh Quoc-Dien²,Kibel Adam S.²,Taplin Mary-Ellen²

Affiliation:

1. University of California San Diego, La Jolla, California

2. Dana-Farber Cancer Institute, Boston, Massachusetts

3. University of California Los Angeles, Los Angeles, California

4. Beth Israel Deaconess Medical Center, Boston, Massachusetts

5. Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer;European Urology;2024-08

2. Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer;European Urology;2024-08

3. Circulating Lipid Profiles Associated With Resistance to Androgen Deprivation Therapy in Localized Prostate Cancer;JCO Precision Oncology;2024-07

4. Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis;Clinical Genitourinary Cancer;2024-06

5. Comparison of the efficacy and safety profiles of generic and branded leuprorelin acetate microspheres in patients with prostate cancer;Oncology Letters;2024-05-14